235766 Assessing factors that affect the implementation of an evidence-based colorectal cancer screening intervention: A report from the CNA Health ACTION Partnership

Monday, October 31, 2011

Amanda Borsky, MPP , Health Research and Policy, CNA, Alexandria, VA
Dan Harris, PhD , Health Research and Policy, CNA, Alexandria, VA
Mona Sarfaty, MD MPH , School of Population Health, Thomas Jefferson University, Philadelphia, PA
Ronald Myers, PhD , Medical Oncology, Thomas Jefferson University, Philadelphia, PA
Randa Sifri, MD , Department of Family and Community Medicine, Thomas Jefferson University, Philadelphia, PA
Brian Stello, MD , Department of Family Medicine, Lehigh Valley Hospital, Allentown, PA
Melanie Johnson, MPA , Department of Family Medicine, Lehigh Valley Hospital, Allentown, PA
James Cocroft, MA , Thomas Jefferson University, Philadelphia, PA
Nancy Gratz, MPA , Department of Family Medicine, Lehigh Valley Hospital, Allentown, PA
Martha Kasper-Keintz, ScM , Thomas Jefferson University, Philadelphia, PA
Valerie Pracilio, MPH , Thomas Jefferson University, Philadelphia, PA
Screening for colorectal cancer (CRC) can prevent morbidity and mortality; however, screening is sub-optimal despite availability of evidence-based principles for successful programs. There are individual, organizational, and environmental factors that affect the implementation of interventions to improve CRC screening. To understand the impact of these factors, we assessed the implementation of a population-based intervention using the Practical, Robust, Implementation and Sustainability Model (PRISM).

Through a centralized organization, we implemented the System Approach to Tracking and Increasing Screening for Public Health Improvement of Colorectal Cancer intervention in 15 primary care practices. The six-step intervention provided a mechanism to assist practices with screening and an educational component to inform and change the behavior of both patients and clinicians. We used PRISM to guide the development of the intervention and the assessment of its implementation.

Despite some implementation challenges, the intervention was effective. It was adopted by the primary care practices and reached the target patient population. Logistic regression analyses demonstrated that it was effective in increasing CRC screening. The PRISM framework provided a useful tool for assessing factors affecting the intervention's implementation. Such factors included patient's confidence in their clinicians, the ease at which screening was made available, the organization's ability to use electronic medical records, competing interests within the practices, and clinicians recommendation of guideline concordant screening. We disseminated these findings to others wanting to adopt the intervention.

Identifying and learning from these contextual factors using PRISM will help other organizations implement this and similar cancer screening interventions in future settings.

Learning Areas:
Chronic disease management and prevention
Conduct evaluation related to programs, research, and other areas of practice
Implementation of health education strategies, interventions and programs
Public health or related research

Learning Objectives:
Identify and assess individual, community, and environmental factors that affect the implementation of a colorectal cancer screening intervention. Explain how the Practical, Robust, Implementation and Sustainability Model (PRISM) can be used to evaluate colorectal cancer screening interventions and other public health interventions. Assess the likelihood of other CRC screening interventions being successfully implemented by understanding factors that influence implementation.

Keywords: Cancer Prevention, Cancer Screening

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am the project manager and director on studies related to public health issues such as chronic disease prevention.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.